Xin Zhao, PhD

Xin Zhao, PhD is Global Value Access Lead at Norstella. Dr. Zhao has extensive market access experiences in both consultancy and the pharmaceutical industry. She is experienced in global, early, and late-stage asset development strategy and has covered the therapy areas of oncology, respiratory, immunotherapy, rare diseases, and neurologic disorders. She has an in-depth understanding of the healthcare system in the U.S. and HTA markets (U.K., EU4, Canada) and APAC region (Australia, China, Japan, South Korea, and Taiwan).